Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

International risk of the new variant COVID-19 importations originating in the United Kingdom

Zhanwei Du, Lin Wang, Bingyi Yang, Sheikh Taslim Ali, Tim K. Tsang, Songwei Shan, Peng Wu, View ORCID ProfileEric H. Y. Lau, Benjamin J. Cowling, View ORCID ProfileLauren Ancel Meyers
doi: https://doi.org/10.1101/2021.01.09.21249384
Zhanwei Du
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Wang
3University of Cambridge, Cambridge CB2 3EH, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bingyi Yang
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheikh Taslim Ali
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim K. Tsang
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Songwei Shan
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Wu
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric H. Y. Lau
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric H. Y. Lau
Benjamin J. Cowling
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
2Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bcowling@hku.hk laurenmeyers@austin.utexas.com
Lauren Ancel Meyers
4The University of Texas at Austin, Austin, Texas 78712, The United States of America
5Santa Fe Institute, Santa Fe, New Mexico, The United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren Ancel Meyers
  • For correspondence: bcowling@hku.hk laurenmeyers@austin.utexas.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

A fast-spreading SARS-CoV-2 variant identified in the United Kingdom in December 2020 has raised international alarm. We estimate that, in 16 out of 19 countries analyzed, there is at least a 50% chance the variant was imported by travelers from the United Kingdom by December 7th.

Article Summary Line The new variant COVID-19 has likely been introduced by travelers from the UK and spreading undetected for months in many countries.

The United Kingdom (UK) has detected a new variant of SARS-CoV-2 from samples initially taken in Kent on September 20th and London on September 21st, 2020 1,2, which was found associated with increased transmissibility 3–5. The UK government tightened measures in London and southeast England in mid-December to mitigate the transmission of the fast-spreading virus variant that includes deletions at amino acid sites 69 and 70 of the spike protein 6. On January 5th, 2021, England initiated a national lockdown including closure of all schools and non-essential businesses until mid-February 7. By December 20th, over 40 countries had implemented travel restrictions on travellers from the UK 8. The new variant was subsequently reported worldwide, including in the USA 9, Spain, Sweden and France, and might be spreading without detection in countries with limited virus sequencing capacity 8.

We collected the data from 19 countries and estimated the probability of introduction of this new variant by travellers from the UK to each of these countries and the extent of local transmission, based on the changing proportion of the new variant among infections identified in the UK 5 and population mobility from UK to each country, as estimated from Facebook Data for Good 10.

Ireland and Hungary had the highest and lowest importation risk between September 22 and December 7, 2020, respectively. By October 22nd (a month after its first detection in the UK), 13 of the 19 countries had at least a 50% chance of receiving one importation case from the UK (Figure 1), except for Turkey, Bulgaria, Cyprus, United Arab Emirates, Sweden, and Hungary, while Turkey, Bulgaria and Cyprus had exceeded this risk threshold by November 1st.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Estimated risks for introduction of the 501Y variant of SARS-CoV-2 from the UK to other 19 countries before December 7, 2020.

(A) The probability that at least one person infected with the new COVID-19 variant has arrived at the target country from the UK by the date indicated on the x-axis, based on Facebook mobility data. (B) Estimated daily prevalence of the 501Y variant of SARS-CoV-2 in 19 countries between September 22 and December 7, 2020, assuming that the variant is σ= 50% more transmissible than the 501N variant 4. Points and bands indicate means and standard deviations based on 100 simulations. (C) Risk of at least one importation by November 1, 2020 (also indicated as line colors in A). The 16 countries above and 3 countries below the risk threshold of 50% are indicated in red and bluegreen, respectively. Grey indicates countries/regions where mobility data were not available.

Using COVID-19 hospital admission data 11, we further estimated the local prevalence of the new virus variant in 11 of the 19 countries, assuming that the new variant is 50% more transmissible than the circulating 501N strain 4 (Figure 1). The variant appears to have ascended fastest in Ireland before slowing in mid November and is expected to be spreading rapidly in many of the other countries. As of December 7, Belgium has the highest expected prevalence of the variant (8 [95% CI: 0-68] cases per 100,000) and Ireland has the highest expected proportion of COVID-19 cases caused by the new variant (1% [95% CI: 0-9%]) (Figures 1, S1 and S2).

These projections suggested that countries with substantial population movement from the UK were likely to harbor cases of the new variant by late October, 2020. Our conclusions were based on several key assumptions. The mobility estimates might be demographically biased by the user profile of Facebook, a major social media company with ∼2.7 billion monthly active users in the third quarter of 2020 12. We assume that all introductions during this early period occurred via travelers from the UK and ignore possible importations from other countries, and thus may slightly underestimate the rate of global expansion. Furthermore, we assumed a 10-day lag between infection and hospitalization based on estimates from the United States 13 and Europe 14 and the same natural history and symptomatic proportion shared by the two variants (501Y and 501N) 5. We estimate the daily prevalence of the new strain using the method introduced in ref. 5, under the simplifying assumption that the variant and wildtype share the same natural history and symptomatic proportion. We expect that the estimates will improve as reconstructed linelists 15 and more granular epidemiological data reduce uncertainty in these key epidemiological quantities. However, our findings should be robust in suggesting that the new virus variant has likely been introduced by travelers from the UK and spreading undetected for months in many countries.

Data Availability

Not applicable

Acknowledgements

Financial support was provided by the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. COVID190118), the US National Institutes of Health (grant no. R01 AI151176) and CDC COVID Supplement (grant no. U01IP001136).

Dr. Zhanwei Du is a research assistant professor in the School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. He develops mathematical models to elucidate the transmission dynamics, surveillance and control of infectious diseases.

Footnotes

  • Revision.

References

  1. 1.↵
    Mutant coronavirus in the United Kingdom sets off alarms, but its importance remains unclear. https://www.sciencemag.org/news/2020/12/mutant-coronavirus-united-kingdom-sets-alarms-its-importance-remains-unclear (2020).
  2. 2.↵
    Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).
  3. 3.↵
    Report 42 - Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-42-sars-cov-2-variant/.
  4. 4.↵
    Davies, N. G., Barnard, R. C., Jarvis, C. I. & Kucharski, A. J. Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv (2020).
  5. 5.↵
    Leung, K., Shum, M. H. H., Leung, G. M., Lam, T. T. Y. & Wu, J. T. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Eurosurveillance 26, 2002106 (2021).
    OpenUrl
  6. 6.↵
    Kupferschmidt, K. Fast-spreading U.K. virus variant raises alarms. Science 371, 9–10 (2021).
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Clark, N. National lockdown – Boris Johnson orders nation to stay at home until middle of February as 13.5m Brits get C. The Sun (2021).
  8. 8.↵
    BBC News. Coronavirus: Cases of new variant appear worldwide. BBC (2020).
  9. 9.↵
    CDC. Emerging SARS-CoV-2 Variants. https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html (2020).
  10. 10.↵
    Home - Facebook Data for Good. https://dataforgood.fb.com/.
  11. 11.↵
    Coronavirus (COVID-19) Hospitalizations. https://ourworldindata.org/covid-hospitalizations.
  12. 12.↵
    Number of monthly active Facebook users worldwide as of 3rd quarter 2020. https://www.statista.com/statistics/264810/number-of-monthly-active-facebook-users-worldwide/.
  13. 13.↵
    Aleta, A. et al. Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nat Hum Behav (2020) doi: 10.1038/s41562-020-0931-9.
    OpenUrlCrossRefPubMed
  14. 14.↵
    ISARIC. International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC). COVID-19 Report: 19. https://media.tghn.org/medialibrary/2020/05/ISARIC_Data_Platform_COVID-19_Report_19MAY20.pdf (2020).
  15. 15.↵
    2019nCOV. MOBS Lab https://www.mobs-lab.org/2019ncov.html.
Back to top
PreviousNext
Posted February 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
International risk of the new variant COVID-19 importations originating in the United Kingdom
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
International risk of the new variant COVID-19 importations originating in the United Kingdom
Zhanwei Du, Lin Wang, Bingyi Yang, Sheikh Taslim Ali, Tim K. Tsang, Songwei Shan, Peng Wu, Eric H. Y. Lau, Benjamin J. Cowling, Lauren Ancel Meyers
medRxiv 2021.01.09.21249384; doi: https://doi.org/10.1101/2021.01.09.21249384
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
International risk of the new variant COVID-19 importations originating in the United Kingdom
Zhanwei Du, Lin Wang, Bingyi Yang, Sheikh Taslim Ali, Tim K. Tsang, Songwei Shan, Peng Wu, Eric H. Y. Lau, Benjamin J. Cowling, Lauren Ancel Meyers
medRxiv 2021.01.09.21249384; doi: https://doi.org/10.1101/2021.01.09.21249384

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (419)
  • Anesthesia (97)
  • Cardiovascular Medicine (894)
  • Dentistry and Oral Medicine (166)
  • Dermatology (101)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (404)
  • Epidemiology (8744)
  • Forensic Medicine (4)
  • Gastroenterology (403)
  • Genetic and Genomic Medicine (1845)
  • Geriatric Medicine (175)
  • Health Economics (386)
  • Health Informatics (1281)
  • Health Policy (642)
  • Health Systems and Quality Improvement (489)
  • Hematology (206)
  • HIV/AIDS (387)
  • Infectious Diseases (except HIV/AIDS) (10520)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (216)
  • Neurology (1744)
  • Nursing (100)
  • Nutrition (264)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (457)
  • Oncology (959)
  • Ophthalmology (279)
  • Orthopedics (107)
  • Otolaryngology (174)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (262)
  • Pediatrics (553)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1836)
  • Public and Global Health (3963)
  • Radiology and Imaging (649)
  • Rehabilitation Medicine and Physical Therapy (340)
  • Respiratory Medicine (532)
  • Rheumatology (214)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (165)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (105)
  • Urology (78)